Results for tag: "Neck Squamous Cell Carcinoma Drug"

Neck Squamous Cell Carcinoma (NSCC) is a type of cancer that affects the cells of the neck and throat. It is the most common type of head and neck cancer and is typically treated with a combination of surgery, radiation, and chemotherapy. Oncology drugs are used to treat NSCC, including targeted therapies, immunotherapies, and chemotherapy. Targeted therapies are designed to target specific molecules or pathways in cancer cells, while immunotherapies are designed to boost the body’s own immune system to fight cancer. Chemotherapy is used to kill cancer cells and can be used alone or in combination with other treatments. The NSCC drug market is highly competitive, with a number of companies offering treatments for the disease. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Roche. Other companies such as Novartis, Eli Lilly, and GlaxoSmithKline also offer treatments for NSCC. Show Less Read more